Output 2004
Research articles in refereed specialist journals
European Journal of Cancer
de Wit R, Herrstedt J, Rapoport BL, Carides AD, Guoguang-Ma J, Elmer M, Schmidt C, Evans D, Horgan KJ: 2004. The oral NK[1] antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised placebo-controlled phase III clinical trials. 40, pp 403-410.
|
